J06A
Immune sera Antiserum is a blood serum containing monoclonal or polyclonal antibodies that is used to spread passive immunity to many diseases via blood donation (plasmapheresis). For example, convalescent serum, passive antibody transfusion from a previous ...

J06AA Immune sera

:J06AA01

Diphtheria antitoxin Diphtheria antitoxin (DAT) is a medication made up of antibodies used in the treatment of diphtheria. It is no longer recommended for prevention of diphtheria. It is given by injection into a vein or muscle. Side effects are common. They inclu ...

:J06AA02

Tetanus antitoxin Anti-tetanus immunoglobulin, also known as tetanus immune globulin (TIG) and tetanus antitoxin, is a medication made up of antibodies against the tetanus toxin. It is used to prevent tetanus in those who have a wound that is at high risk, have ...

:J06AA03 Snake venom antiserum :J06AA04 Botulinum antitoxin :J06AA05 Gas-gangrene sera :J06AA06 Rabies serum

J06B Immunoglobulins

J06BA Immunoglobulins, normal human

:J06BA01 Immunoglobulins, normal human, for extravascular administration :J06BA02 Immunoglobulins, normal human, for intravascular administration

J06BB Specific
immunoglobulins An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein used by the immune system to identify and neutralize foreign objects such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the ...

:J06BB01 Anti-D (rh) immunoglobulin :J06BB02

Tetanus Tetanus, also known as lockjaw, is a bacterial infection caused by ''Clostridium tetani'', and is characterized by muscle spasms. In the most common type, the spasms begin in the jaw and then progress to the rest of the body. Each spasm usually ...

immunoglobulin :J06BB03 Varicella/zoster immunoglobulin :J06BB04

Hepatitis B immunoglobulin Hepatitis B immunoglobulin (HBIG) is a human immunoglobulin that is used to prevent the development of hepatitis B and is used for the treatment of acute exposure to HBsAg. Medical uses HBIG is indicated as a postexposure prophylaxis for people ...

:J06BB05

Rabies Rabies is a viral disease that causes encephalitis in humans and other mammals. Early symptoms can include fever and tingling at the site of exposure. These symptoms are followed by one or more of the following symptoms: nausea, vomiting, vi ...

immunoglobulin :J06BB06

Rubella Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and ...

immunoglobulin :J06BB07

Vaccinia ''Vaccinia virus'' (VACV or VV) is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, which encodes approximately 250 genes. The dimensions of the ...

immunoglobulin :J06BB08

Staphylococcus ''Staphylococcus'' is a genus of Gram-positive bacteria in the family Staphylococcaceae from the order Bacillales. Under the microscope, they appear spherical (cocci), and form in grape-like clusters. ''Staphylococcus'' species are facultative ...

immunoglobulin :J06BB09

Cytomegalovirus ''Cytomegalovirus'' (''CMV'') (from ''cyto-'' 'cell' via Greek - 'container' + 'big, megalo-' + -''virus'' via Latin 'poison') is a genus of viruses in the order ''Herpesvirales'', in the family ''Herpesviridae'', in the subfamily ''Betaherpe ...

immunoglobulin :J06BB10

Diphtheria Diphtheria is an infection caused by the bacterium '' Corynebacterium diphtheriae''. Most infections are asymptomatic or have a mild clinical course, but in some outbreaks more than 10% of those diagnosed with the disease may die. Signs and s ...

immunoglobulin :J06BB11

Hepatitis A Hepatitis A is an infectious disease of the liver caused by ''Hepatovirus A'' (HAV); it is a type of viral hepatitis. Many cases have few or no symptoms, especially in the young. The time between infection and symptoms, in those who develop them ...

immunoglobulin :J06BB12 Encephalitis, tick-borne immunoglobulin :J06BB13

Pertussis Whooping cough, also known as pertussis or the 100-day cough, is a highly contagious bacterial disease. Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, but these are followed by two or ...

immunoglobulin :J06BB14 Morbilli immunoglobulin :J06BB15

Parotitis Parotitis is an inflammation of one or both parotid glands, the major salivary glands located on either side of the face, in humans. The parotid gland is the salivary gland most commonly affected by inflammation. Etymology From Greek παρωτῖ ...

immunoglobulin :J06BB19

Anthrax Anthrax is an infection caused by the bacterium ''Bacillus anthracis''. It can occur in four forms: skin, lungs, intestinal, and injection. Symptom onset occurs between one day and more than two months after the infection is contracted. The sk ...

immunoglobulin :J06BB30 Combinations

J06BC Antibacterial monoclonal antibodies

:J06BC01 Nebacumab :J06BC02

Raxibacumab Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys. In December 2012 raxibacumab was approved in the United States for the treatment of in ...

:J06BC03

Bezlotoxumab Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of ''Clostridioides difficile'' infections. This drug, along with actoxumab, was developed through Phase II efficacy trials ...

:J06BC04

Obiltoxaximab Obiltoxaximab, sold under the brand name Anthim, is a monoclonal antibody medication designed for the treatment of exposure to ''Bacillus anthracis'' spores (etiologic agent of anthrax). The medication was developed by Elusys Therapeutics, Inc. * ...

J06BD Antiviral monoclonal antibodies

:J06BD01

Palivizumab Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants at high-risk for RS ...

:J06BD02 Motavizumab :J06BD03 Tixagevimab and cilgavimab :J06BD04

Ansuvimab Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of ''Zaire ebolavirus'' (Ebolavirus) infection. The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypote ...

:J06BD05

Sotrovimab Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus 2, known as SARS-CoV-2. Text was copied from this source which is copyright European M ...

:J06BD06 Regdanvimab :J06BD07 Casirivimab and imdevimab :J06BD08

Nirsevimab Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus, or RSV for infants. It is under development by AstraZeneca and Sanofi. Nirsevimab is designed to bind ...

References

{{Immune sera and immunoglobulins J06

J06A Immune sera Antiserum is a blood serum containing monoclonal or polyclonal antibodies that is used to spread passive immunity to many diseases via blood donation (plasmapheresis). For example, convalescent serum, passive antibody transfusion from a previous ...